A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
暂无分享，去创建一个
A. López-Guillermo | O. Casasnovas | P. Zinzani | W. Kim | C. Carlo-Stella | V. Ribrag | G. Abbadessa | G. Cartron | S. Yeh | A. Sureda | S. le Gouill | M. Chamuleau | C. Carpio | R. Cordoba | A. Re | K. Bouabdallah | Youngil Koh | Ran Ji | I. Moreira | M. V. D. van der Poel | Rao Saleem | D. Alves | R. Meng | Luc Lépine | L. Araújo | Y. Koh | R. Córdoba | M. van der Poel